ARX vs IMC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

IMC

IMMURON FPO [IMC]

53MEDIUM

Score Breakdown

ARX IMC
Technical
38
66
Catalyst
50
51
Sentiment
50
50
Fundamental
95
56
Momentum
55
39
Risk Gate
50
42

Key Metrics

ARX Metric IMC
$202.9MMarket Cap$13.9M
314KAvg Volume (20d)321K
N/AShort InterestN/A
$0.80052-Week High$0.098
$0.49552-Week Low$0.026
-0.8%Daily Change+0.0%
$0.580Reference Price$0.043
+4.9%ROE-39.7%
+4.5%Profit Margin-62.1%

Active Signals

ARX Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Above-average volume (1.6x) on a red day — sellers in control
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 3.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (2.0x)

IMC Signals

MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Trading above both moving averages — the trend is your friend here
On a tear — up 10.3% over the last 5 days
Beating the Small Ords index — relative strength of 1.32, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (9 quarters)
Low P/S ratio (1.9x)

Ask Scout AI to compare ARX and IMC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs IMM →ARX vs LDX →ARX vs MAP →ARX vs MYX →ARX vs NAN →
ARX Full Analysis → IMC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).